Global Longlife Hospital and Research Share Price
12.19+0.40 (+3.39%)
-51.41% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | -100% |
| - | - | - | -965% |
| - | - | -37% | -53% |
| 6% | 5% | -4% | -7% |
Peer Comparison
Symbol
APOLLOHOSP-A
MAXHEALTH-A
FORTIS-A
ASTERDM-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
GLHRL-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,675 | ₹126300 Cr | 60.45 | 40.39 | 207.67 | ₹1942 Cr |
| 993.9 | ₹96763 Cr | 66.42 | 3.31 | 19.84 | ₹1442 Cr |
| 911.55 | ₹68901 Cr | 65.75 | 3.53 | 20.1 | ₹1042 Cr |
| 789.7 | ₹68592 Cr | 215.24 | 0.31 | 6.76 | ₹464 Cr |
| 1,866.1 | ₹38439 Cr | 47.1 | 10.14 | 65.36 | ₹806 Cr |
| 1,481.3 | ₹38149 Cr | 68.59 | 5.91 | 29.85 | ₹556 Cr |
| 1,876 | ₹32259 Cr | 59.53 | 10.11 | 42.51 | ₹505 Cr |
| 766.7 | ₹32231 Cr | 157.77 | 1.04 | 12.74 | ₹241 Cr |
| 508.4 | ₹16249 Cr | 109.52 | 1.43 | 13.88 | ₹133 Cr |
| 1,495.15 | ₹15511 Cr | 82.73 | 5.16 | 27.53 | ₹173 Cr |
| 12.19 | ₹12 Cr | — | — | -1.64 | -₹2 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — |
| ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr |
| ₹13 Cr | ₹16 Cr | ₹15 Cr | ₹54 Cr | ₹10 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr |
| ₹13 Cr | ₹16 Cr | ₹15 Cr | ₹54 Cr | ₹10 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr |
| ₹24 Cr | ₹27 Cr | ₹26 Cr | ₹64 Cr | ₹17 Cr | ₹14 Cr | ₹11 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹3 Cr | ₹82 L | ₹0 | ₹10 Cr | ₹11 Cr | ₹12 Cr |
| ₹0 | ₹0 | ₹59 L | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹6 Cr |
| -₹2 Cr | -₹2 Cr | -₹2 Cr | -₹2 Cr | -₹3 Cr | -₹4 Cr | -₹3 Cr | -₹3 Cr |
| ₹0 | ₹0 | ₹89,000 | ₹9 L | ₹36 L | ₹31 L | ₹35 L | ₹33 L |
| ₹0 | ₹0 | ₹5 L | ₹8 L | ₹6 L | ₹5 L | ₹0 | ₹0 |
| -₹2 Cr | -₹2 Cr | ₹1 Cr | ₹2 Cr | ₹67 L | ₹9 Cr | ₹14 Cr | ₹15 Cr |
| — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹3 Cr | ₹1 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹3 Cr |
| ₹0 | ₹1 L | ₹1 Cr | ₹56 L | ₹12 Cr | ₹4 Cr | ₹2 Cr | ₹4 Cr |
| ₹0 | ₹0 | ₹8 Cr | ₹5 Cr | -₹4 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr |
| ₹1 L | ₹4 L | ₹2 L | ₹47 L | ₹1 Cr | ₹1 L | ₹22 L | ₹30 L |
| ₹1 L | ₹6 L | ₹12 Cr | ₹8 Cr | ₹14 Cr | ₹10 Cr | ₹13 Cr | ₹13 Cr |
| ₹21 Cr | ₹24 Cr | ₹40 Cr | ₹74 Cr | ₹31 Cr | ₹33 Cr | ₹39 Cr | ₹40 Cr |
| ₹0 | ₹0 | ₹6 Cr | ₹8 Cr | ₹14 Cr | ₹16 Cr | ₹14 Cr | ₹14 Cr |
| ₹0 | ₹0 | ₹13 Cr | ₹9 Cr | ₹9 Cr | ₹17 Cr | ₹24 Cr | ₹27 Cr |
| — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹26 Cr | ₹20 Cr | ₹22 Cr |
| ₹0 | ₹0 | ₹12 Cr | ₹11 Cr | ₹9 Cr | ₹8 Cr | ₹2 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹19 Cr | ₹20 Cr |
| ₹0 | ₹0 | ₹0 | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹0 | ₹3 L | ₹3 L | ₹10 L | ₹10 L | ₹10 L | ₹10 L | ₹10 L |
| ₹0 | ₹3 L | ₹3 L | ₹10 L | ₹10 L | ₹10 L | ₹10 L | ₹10 L |
| ₹90,000 | ₹90,000 | ₹16 Cr | ₹20 Cr | ₹21 L | ₹21 L | ₹4 Cr | ₹5 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹5 L | ₹0 | ₹0 | ₹0 |
| ₹90,000 | ₹4 L | ₹33 Cr | ₹38 Cr | ₹17 Cr | ₹18 Cr | ₹23 Cr | ₹25 Cr |
| — | — | — | — | — | — | — | — |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹37 L | ₹0 | ₹0 |
| ₹0 | ₹0 | ₹44 L | ₹82 L | ₹88 L | ₹81 L | ₹2 Cr | ₹2 Cr |
| ₹23 L | ₹32 L | ₹2 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹6 Cr | ₹9 Cr |
| ₹17 Cr | ₹21 Cr | ₹39 L | ₹4 Cr | ₹22 L | ₹44 L | ₹1 Cr | ₹48 L |
| ₹3 Cr | ₹52 L | ₹2 L | ₹18 Cr | ₹2 L | ₹0 | ₹53 L | ₹77 L |
| ₹95,000 | ₹31 L | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr |
| ₹20 Cr | ₹23 Cr | ₹4 Cr | ₹34 Cr | ₹11 Cr | ₹12 Cr | ₹16 Cr | ₹15 Cr |
| ₹20 Cr | ₹23 Cr | -₹8 Cr | ₹26 Cr | -₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹0 | ₹0 |
| ₹21 Cr | ₹24 Cr | ₹40 Cr | ₹74 Cr | ₹31 Cr | ₹33 Cr | ₹39 Cr | ₹40 Cr |
| ₹22 | ₹24 | ₹23 | ₹59 | ₹20 | ₹14 | ₹16 | ₹18 |
| ₹22 | ₹24 | ₹23 | ₹59 | ₹20 | ₹14 | ₹16 | ₹18 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|
| -₹99 L | ₹10 L | -₹2 Cr | ₹3 Cr | ₹6 Cr | ₹2 Cr | -₹1 Cr | ₹3 Cr |
| -₹62 L | -₹3 Cr | -₹34 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| -₹2 Cr | ₹15 Cr | ₹31 Cr | -₹44 Cr | ₹16 L | ₹1 Cr | ₹49 L | -₹1 Cr |
| -₹4 Cr | ₹13 Cr | -₹5 Cr | -₹39 Cr | ₹9 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr |
| -₹5 Cr | ₹12 Cr | -₹5 Cr | -₹40 Cr | ₹9 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr |
| ₹4 L | ₹22 Cr | -₹82 L | -₹2 Cr | ₹1 L | ₹2 L | -₹4 L | -₹33 L |
| -₹3,000 | -₹13 Cr | ₹3 Cr | ₹46 Cr | -₹10 Cr | -₹7 Cr | -₹3 Cr | -₹5 Cr |
| -₹4 Cr | ₹21 Cr | -₹3 Cr | ₹3 Cr | -₹22 L | -₹33 L | ₹81 L | ₹31 L |
| ₹21 Cr | ₹39 L | ₹4 Cr | ₹22 L | ₹44 L | ₹77 L | ₹48 L | ₹17 L |
| ₹17 Cr | ₹21 Cr | ₹39 L | ₹4 Cr | ₹22 L | ₹44 L | ₹1 Cr | ₹48 L |
Fundamental Ratios
Consolidated
Standalone
No results found